Stay updated with breaking news from Ysopia Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive...
MONT-SAINT-GUIBERT, Belgium, March 24, 2023 -- Celyad Oncology , a biotechnology company focused on innovative technologies for chimeric antigen receptor T-cell therapies, is pleased to announce... | March 24, 2023
24.03.2023 - Regulatory News: Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, is pleased to announce Georges Rawadi as its new Chief ... Seite 1
Regulatory News: Celyad Oncology (Euronext Nasdaq: CYAD) (the "Company"), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, is pleased
/PRNewswire/ -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global Microbiome Therapeutics...